A comprehensive view of eli lilly & co.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
INTERNATIONAL PATENT: ELI LILLY AND COMPANY FILES APPLICATION FOR "COMPOSITIONS OF EXTENDED RELEASE COATINGS AND METHODS FOR APPLYING EXTENDED RELEASE COATINGS"
Published:
February 01, 2023
by U.S. Fed News
|
US Patent Issued to Eli Lilly and Co. on Jan. 31 for "Combination therapy with Notch and PI3K/mTOR inhibitors for use in treating cancer" (Indiana Inventors)
Published:
February 01, 2023
by U.S. Fed News
|
Darryle D. Schoepp, Ph.D., former Merck and Eli Lilly executive, joins Scientific Advisory Board of Akelos Inc., a biotechnology company developing opioid alternatives; Dr. Schoepp recently retired from Merck after 30 years in the pharmaceutical industry
Published:
February 01, 2023
by Newswire.com
|
Eli Lilly and Company Seeks Patent for Novel RNA Therapeutics and Uses Thereof
Published:
January 30, 2023
by Biotechnology Patent News
|
Eli Lilly and Company Submits Patent Application for CD73 Inhibitors
Published:
January 27, 2023
by Pharmaceutical Patent News
|
Ask us about our Health Care Sector market view
Trending Chart
Interactive chart with headline count